‘Heads down and working’: Mesoblast boss unfazed as Novartis deal ends

Stem cell treatments maker Mesoblast’s shares have taken a hit after the company said its $US50 million partnership with biotech giant Novartis has fizzled out.

Brisbane Times – Business

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Business